Already a member? Sign in
Ceftriaxone is a third-generation cephalosporin antibiotic that is used as a broad spectrum agent in the treatment of many types of infections. Off label it is used for sexually-transmitted diseases, Lyme disease, community-acquired pneumonia, typhoid fever and Whipple's disease.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| ALS (Amyotrophic Lateral Sclerosis) | 26 | 6 |
|
|
|
||
| Lyme Disease | 14 | 3 |
|
|
|
||
| Other | 10 | 0 | |||||
| Lyme Disease | 7 | 3 |
|
|
|||
| UTI (Urinary Tract Infection) | 3 | 0 | |||||
| Participate in clinical trial | 2 | 2 |
|
See all 18 patients currently taking Ceftriaxone
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Ceftriaxone
| Gallbladder removal (Cholecystectomy) | 2 | |
|---|---|---|
| Diarrhea | 1 | |
| Rash or skin problems | 1 | |
| Gallbladder problems | 1 | |
| Burning sensation in eyes | 1 | |
| Gas | 1 | |
| See all 11 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Ceftriaxone. See all 11 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Course of treatment ended | 19 | ||
| Did not seem to work | 12 | ||
| Doctor's advice | 11 | ||
| Other | 8 | ||
| Side effects too severe | 6 | ||
| Not indicated | 4 | ||
| Expense | 1 |
Adherence
Taking treatment as prescribed
Adherence of Ceftriaxone
Always |
14 | 100% |
|
|---|---|---|---|
Usually |
0 | 0% |
|
Sometimes |
0 | 0% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Ceftriaxone
Very |
4 | 29% |
|
|---|---|---|---|
Somewhat |
1 | 7% |
|
A little |
6 | 43% |
|
Not at all |
3 | 21% |
|
Cost
Paid out of pocket
Cost of Ceftriaxone
$200+ |
3 | 30% |
|
|---|---|---|---|
$100-199 |
2 | 20% |
|
$50-99 |
0 | 0% |
|
$25-49 |
0 | 0% |
|
< $25 |
5 | 50% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 26, 2012.